Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Seb James stepping down as Boots managing director

(Sharecast News) - Walgreens Boots Alliance announced on Monday that Sebastian James, managing director of Boots, had decided to leave the company to pursue a new role in the healthcare sector. The Nasdaq-listed pharmacy, health and beauty retail giant said James, along with Ornella Barra and the Boots senior leadership team, had helped to transform Boots into the UK's leading health and beauty retailer.

It noted that the chain had experienced 13 consecutive quarters of retail market share growth, with recent strong third-quarter results in June showing growth across all categories.

The news came amid recent market rumours that Walgreens had again put plans to sell the Boots business on hold, having confirmed in May it was keen to talk to potential suitors.

"On behalf of all colleagues at WBA and Boots, I would like to thank Seb for his role in the success of the business over the past years," said Ornella Barra, chief operating officer international at Walgreens Boots Alliance.

"His tenure has seen the company transform through a steadfast focus on investment, innovation and growth into the number one health and beauty destination in the UK.

"We thank Sebastian for his commitment - together with the Boots leadership team - to delivering a strong platform for success and sustainable, long-term growth, and wish him all the best for his next endeavour."

The company said that since his appointment in 2018, James had revitalised the Boots beauty business, introducing hundreds of new brands, renovating stores, and hiring more specialist beauty advisors.

Additionally, under his leadership, Boots had expanded its services, offering over 160 healthcare services for both private and NHS patients, reinforcing its position as the UK's largest pharmacy and a leading healthcare provider.

James would remain with Boots until November as the company started the recruitment process for a new managing director.

"It has been a pleasure to lead this fantastic company and support its transformation during my time as managing director," Sebastian James added.

"Now in its 175th year, Boots has shaped how people access health and beauty products on the high street and I am proud to have been part of a business that continues to hold a critical role at the centre of the UK health and beauty sectors.

"I look forward to seeing the business continue to succeed under its excellent leadership team."

At 0515 EDT (1015 BST), shares in Walgreens Boots Alliance were up 0.29% in premarket trading on the Nasdaq, at $12.13.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Tritax Eurobox says Brookfield offer deadline extended; in talks with other parties
(Sharecast News) - Tritax Eurobox rallied on Tuesday after it said the deadline for Brookfield Asset Management to make an offer for the company has been extended, and that it had received other expressions of interest from a number of parties.
Caspian Sunrise reports progress on several fronts
(Sharecast News) - Caspian Sunrise updated the market on its recent activities on Tuesday, including well testing results, new drilling, and preparations for the charter of the Caspian Explorer.
Tesla shares pop on better-than-expected delivery numbers
(Sharecast News) - Tesla shares were rising on Tuesday, after it reported a smaller-than-expected decline in vehicle deliveries for the second quarter on the back of strategic price cuts and incentives designed to boost demand.
CleanTech announces results of plant location study
(Sharecast News) - CleanTech Lithium announced the results of a plant location study on Tuesday, as part of the ongoing pre-feasibility study (PFS) for its Laguna Verde Project in Chile.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.